Latest Period
n/a
Security Snapshot
Cellectar Biosciences, Inc. - Common Shares (CLRB) Institutional Ownership
CUSIP: 15117F500
13F Institutional Holders and Ownership History from Q2 2018 to Q2 2023
Institutions Reporting
Shares (Excl. Options)
Price
Save this security research path
Keep this CUSIP in your research flow, then return after the next filing cycle to check what changed.
- Type / Class
- Equity / Common Shares
- Symbol
- CLRB on Nasdaq
- Shares outstanding
- 4,503,909
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CLRB - Cellectar Biosciences, Inc. - Common Shares is tracked under CUSIP 15117F500.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 0 between Q1 2023 and Q2 2023.
- Reported value moved from $4 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 15117F500?
CUSIP 15117F500 identifies CLRB - Cellectar Biosciences, Inc. - Common Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15117F500:
Significant Owners of Cellectar Biosciences, Inc. - Common Shares (CLRB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 5.5% | -44% | 247,715 | -97% | Rosalind Advisors, Inc. | 31 Dec 2025 | ||
| ADAR1 Capital Management, LLC | 0.1% | 2,962 | ADAR1 Capital Management, LLC | 30 Jun 2025 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q2 | 0 | $0 | -$4 | 0 | |
| 2023 Q1 | 5 | $4 | +$4 | $0.80 | 1 |
| 2022 Q3 | 5 | $1,000 | -$1,914,000 | $200.00 | 1 |
| 2022 Q2 | 4,743,321 | $1,914,000 | -$711,862 | $0.40 | 24 |
| 2022 Q1 | 6,819,353 | $4,688,000 | +$178,821 | $0.69 | 27 |
| 2021 Q4 | 6,591,438 | $4,376,000 | -$753,116 | $0.66 | 35 |
| 2021 Q3 | 7,320,806 | $6,772,000 | -$6,047,136 | $0.92 | 36 |
| 2021 Q2 | 12,486,174 | $14,874,276 | -$4,685,208 | $1.19 | 42 |
| 2021 Q1 | 15,049,405 | $24,219,357 | -$5,794,482 | $1.61 | 42 |
| 2020 Q4 | 17,679,705 | $36,895,000 | +$23,156,825 | $2.08 | 38 |
| 2020 Q3 | 3,452,402 | $4,282,000 | +$542,449 | $1.24 | 19 |
| 2020 Q2 | 3,006,006 | $3,849,000 | +$1,971,582 | $1.28 | 21 |
| 2020 Q1 | 1,466,241 | $1,936,000 | +$222,918 | $1.31 | 15 |
| 2019 Q4 | 1,295,959 | $2,917,000 | -$498,988 | $2.25 | 9 |
| 2019 Q3 | 1,506,159 | $3,006,054 | -$985,030 | $2.00 | 12 |
| 2019 Q2 | 1,985,734 | $4,329,059 | +$3,787,212 | $2.18 | 11 |
| 2019 Q1 | 246,868 | $581,063 | -$32,864 | $2.35 | 9 |
| 2018 Q4 | 262,671 | $407,000 | +$89,332 | $1.55 | 9 |
| 2018 Q3 | 203,047 | $611,000 | +$567,000 | $3.01 | 9 |
| 2018 Q2 | 72,383 | $44,000 | +$44,000 | $0.61 | 1 |